Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.

AIDS (London, England) - 23 Nov 2001

Goudsmit J, Weverling G J, van der Hoek L, de Ronde A, Miedema F, Coutinho R A, Lange J M, Boerlijst M C

Abstract excerpt

OBJECTIVE: Because maintenance of treatment success in HIV-1 infection requires viruses to remain therapy sensitive in drug-naive seropositive persons, we looked at the primary infections caused by drug-resistant HIV-1 over time. Furthermore, to study the coverage rate of therapy and therapy failure in relation to the transmission of resistant viruses a mathematical model was developed. DESIGN: The reverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Carrier State

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Homosexuality, Male

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Share to Zidovudine

Source

Identifiers

PMID: 11698703
DOI: 10.1097/00002030-200111230-00011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.PMID 11698703Read ↗

Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.Semantic proximity Read ↗

Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model.Semantic proximity Read ↗

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.Semantic proximity Read ↗

Mathematical approaches in the study of viral kinetics and drug resistance in HIV-1 infection.Semantic proximity Read ↗

Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection.Semantic proximity Read ↗

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.Semantic proximity Read ↗

Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure.Semantic proximity Read ↗

Declining trend in transmission of drug-resistant HIV-1 in Amsterdam.Semantic proximity Read ↗

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.Semantic proximity Read ↗

The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients.Semantic proximity Read ↗

Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.Semantic proximity Read ↗

Epidemiological models for the spread of anti-malarial resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.